Drug-induced Hypoglycaemia: an Update

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2010 Oct 15

PMID 20942513

Citations 17

Authors

Chaker Ben Salem

Neila Fathallah

Houssem Hmouda

Kamel Bouraoui

Affiliations

Soon will be listed here.

Abstract

Drugs are the most frequent cause of hypoglycaemia in adults. Although hypoglycaemia is a well known adverse effect of antidiabetic agents, it may occasionally develop in the course of treatment with drugs used in everyday clinical practice, including NSAIDs, analgesics, antibacterials, antimalarials, antiarrhythmics, antidepressants and other miscellaneous agents. They induce hypoglycaemia by stimulating insulin release, reducing insulin clearance or interfering with glucose metabolism. Several drugs may also potentiate the hypoglycaemic effect of antidiabetic agents. Administration of these agents to individuals with diabetes mellitus is of most concern. Many of these drugs, and depending on clinical setting, may also induce hyperglycaemia. Drug-induced hepatotoxicity and nephrotoxicity may lead in certain circumstances to hypoglycaemia. Some drugs may also induce hypoglycaemia by causing pancreatitis. Drug-induced hypoglycaemia is usually mild but may be severe. Effective clinical management can be handled through awareness of this drug-induced adverse effect on blood glucose levels. Herein, we review pertinent clinical information on the incidence of drug-induced hypoglycaemia and discuss the underlying pathophysiological mechanisms, and prevention and management.

Citing Articles

Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report.

Nagano Y, Aoki H, David J, Kondo N, Aizawa M, Sumita T J Pharm Health Care Sci. 2025; 11(1):5.

PMID: 39871315 PMC: 11770970. DOI: 10.1186/s40780-024-00406-1.

Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care.

Rossi A, Simeoli C, Pivonello R, Salerno M, Rosano C, Brunetti B Rev Endocr Metab Disord. 2024; 25(4):707-725.

PMID: 38556561 PMC: 11294274. DOI: 10.1007/s11154-024-09880-2.

Pharmacological mechanisms of norcantharidin against hepatocellular carcinoma.

Qian Z, Chen Y, Bao Y Am J Cancer Res. 2023; 13(11):5024-5038.

PMID: 38058814 PMC: 10695805.

Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment.

Maines E, Urru S, Leonardi L, Fancellu E, Campomori A, Piccoli G Rev Endocr Metab Disord. 2023; 24(6):1031-1044.

PMID: 37552352 DOI: 10.1007/s11154-023-09828-y.

Toxicological Evaluation of Novel Cyclohexenone Derivative in an Animal Model through Histopathological and Biochemical Techniques.

Kamil M, Fatima A, Ullah S, Ali G, Khan R, Ismail N Toxics. 2021; 9(6).

PMID: 34070633 PMC: 8227666. DOI: 10.3390/toxics9060119.

References

Petermann W, Odenholt I, Phillips M, Willcox P, Tack K, Trostmann U . A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia. Scand J Infect Dis. 2002; 33(11):832-7. DOI: 10.1080/00365540110076633. View

Bretzel R, Nuber U, Landgraf W, Owens D, Bradley C, Linn T . Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet. 2008; 371(9618):1073-84. DOI: 10.1016/S0140-6736(08)60485-7. View

Fatourechi M, Kudva Y, Murad M, Elamin M, Tabini C, Montori V . Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2008; 94(3):729-40. DOI: 10.1210/jc.2008-1415. View

Goldberg I, Brown L, Rayfield E . Disopyramide (Norpace)-induced hypoglycemia. Am J Med. 1980; 69(3):463-6. DOI: 10.1016/0002-9343(80)90020-0. View

Grandvuillemin A, Jolimoy G, Authier F, Dautriche A, Duhoux F, Sgro C . [Tramadol-induced hypoglycemia. 2 cases]. Presse Med. 2006; 35(12 Pt 1):1842-4. DOI: 10.1016/s0755-4982(06)74913-2. View

Loupi E, Descotes J, Lery N, EVREUX J . [Drug interactions involving miconazole]. Therapie. 1982; 37(4):437-41. View

Johnson J, Dobmeier M . Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction. DICP. 1990; 24(3):250-1. DOI: 10.1177/106002809002400307. View

Marbury T, Huang W, Strange P, Lebovitz H . Repaglinide versus glyburide: a one-year comparison trial. Diabetes Res Clin Pract. 1999; 43(3):155-66. DOI: 10.1016/s0168-8227(99)00002-9. View

Waskin H, Helmick C, Sattler F . Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA. 1988; 260(3):345-7. View

10.

Skrivarhaug T, Bangstad H, Stene L, Sandvik L, Hanssen K, Joner G . Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2005; 49(2):298-305. DOI: 10.1007/s00125-005-0082-6. View

11.

Garbitelli V . Tetracycline reduces the need for insulin. N Y State J Med. 1987; 87(10):576. View

12.

Niemi M, Kajosaari L, Neuvonen M, Backman J, Neuvonen P . The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects. Br J Clin Pharmacol. 2004; 57(4):441-7. PMC: 1884466. DOI: 10.1046/j.1365-2125.2003.02027.x. View

13.

Rendell M . The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs. 2004; 64(12):1339-58. DOI: 10.2165/00003495-200464120-00006. View

14.

Jayasagar G, Dixit A, Kishan V, Rao Y . Effect of clarithromycin on the pharmacokinetics of tolbutamide. Drug Metabol Drug Interact. 2000; 16(3):207-15. DOI: 10.1515/dmdi.2000.16.3.207. View

15.

Nagachandran P, Mendelson A, Edoute Y . Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999; 159(3):281-4. DOI: 10.1001/archinte.159.3.281. View

16.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

17.

Heller S, Amiel S, Mansell P . Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care. 1999; 22(10):1607-11. DOI: 10.2337/diacare.22.10.1607. View

18.

Pan C, Yang W, Barona J, Niggli M, Mohideen P, Wang Y . Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial. Diabet Med. 2008; 25(4):435-41. DOI: 10.1111/j.1464-5491.2008.02391.x. View

19.

HAUGAN S . [Accidental hypothermia during treatment with a neuroleptic agent]. Nord Med. 1966; 75(14):377-80. View

20.

Morris A, Boyle D, McMahon A, Pearce H, Evans J, Newton R . ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit. Diabetes Care. 1997; 20(9):1363-7. DOI: 10.2337/diacare.20.9.1363. View